zika
viru
zikv
belong
genu
flaviviru
within
flavivirida
famili
zikv
envelop
posit
sens
singlestrand
rna
viru
genom
size
kb
encod
singl
polyprotein
posttransl
process
cellular
viral
proteas
three
structur
capsid
c
premembran
prm
envelop
e
seven
nonstructur
protein
tripathi
et
al
avilaperez
et
al
zika
viru
initi
isol
uganda
viral
infect
occur
sporad
africa
asia
zikv
appear
explos
first
largescal
outbreak
occur
yap
island
french
polynesia
weaver
et
al
recent
first
local
transmiss
zikv
found
territori
latin
america
caribbean
result
million
zikv
infect
suspect
case
tang
et
al
tripathi
et
al
like
member
flavivirida
famili
yellow
fever
viru
yfv
dengu
viru
denv
japanes
enceph
viru
jev
west
nile
viru
wnv
zikv
commonli
transmit
bite
infect
aed
mosquito
also
transmit
vertic
mother
child
sexual
contact
rare
case
blood
transfus
lessler
et
al
fink
et
al
upon
infect
zikv
shed
blood
urin
semen
saliva
amniot
fluid
breast
milk
cerebrospin
fluid
nayak
et
al
colt
et
al
nazerai
et
al
peopl
infect
zikv
asymptomat
mild
symptom
fever
rash
joint
pain
conjunct
last
sever
day
week
fink
et
al
rare
case
peopl
symptom
may
neurolog
syndrom
complic
oehler
et
al
riveraconcepcion
et
al
nazerai
et
al
case
pregnant
women
zikv
infect
lead
microcephali
fetal
complic
occur
largescal
zikv
outbreak
brazil
lessler
et
al
signific
outbreak
south
central
north
america
zikv
declar
public
health
concern
world
health
organ
februari
lazear
diamond
ramo
da
silva
gao
weaver
et
al
tripathi
et
al
sever
vaccin
antivir
drug
current
develop
prevent
treatment
zikv
infect
abbink
et
al
larocca
et
al
et
al
fink
et
al
dnabas
abbink
et
al
larocca
et
al
inactiv
abbink
et
al
larocca
et
al
et
al
liveattenu
mrna
richner
et
al
vaccin
propos
prophylact
treatment
zikv
infect
hand
arbidol
arb
fink
et
al
haviernik
et
al
bortezomib
mycophenol
acid
daptomycin
barrow
et
al
obatoclax
saliphenylhalamid
gemcitabin
kuivanen
et
al
emetin
yang
et
al
sofosbuvir
bullardfeibelman
et
al
propos
therapeut
treatment
zikv
infect
despit
tremend
effort
current
food
drug
administr
fda
approv
vaccin
andor
antivir
drug
avail
treatment
zikv
infect
sinc
vaccin
take
least
week
sever
month
show
protect
effect
zikv
infect
vaccin
probabl
appropri
prophylact
method
travel
area
zikv
epidem
endem
alreadi
infect
moreov
vaccin
may
caus
import
issu
antibodydepend
enhanc
ade
bardina
et
al
priyamvada
et
al
ade
extens
describ
denv
priyamvada
et
al
phenomenon
preexist
antibodi
facilit
bind
infect
subsequ
exposur
infecti
virus
instead
neutral
result
exacerb
clinic
sign
bardina
et
al
priyamvada
et
al
structur
similar
denv
zikv
denv
ade
zikv
infect
also
report
bardina
et
al
priyamvada
et
al
sinc
vaccin
zikv
could
lead
denv
ade
antivir
could
repres
better
choic
control
zikv
infect
aurintricarboxyl
acid
ata
polyanion
aromat
compound
shown
inhibitori
properti
sever
bacteria
virus
includ
among
other
yersinia
pesti
liang
et
al
cryptosporidium
parvum
klein
et
al
human
immunodefici
viru
hiv
mitra
et
al
de
clercq
hepat
c
viru
hcv
chen
et
al
mukherje
et
al
shadrick
et
al
vaccinia
viru
myskiw
et
al
influenza
viru
hung
et
al
enteroviru
hung
et
al
sever
acut
respiratori
syndrom
coronavirus
sarscov
et
al
mechanist
studi
suggest
ata
abil
modul
variou
cellular
enzym
activ
janu
kinas
signal
transduc
activ
transcript
famili
rui
et
al
inhibitor
nucleas
shadrick
et
al
dehydrogenas
binastein
tritton
topoisomeras
ii
protein
catchpool
stewart
benchokroun
et
al
well
enzymat
activ
vaccinia
viru
phosphatas
smee
et
al
howev
date
abil
ata
inhibit
zikv
infect
evalu
herein
investig
ata
plausibl
prophylact
therapeut
candid
zikv
infect
result
demonstr
ata
potent
effect
antivir
activ
zikv
pre
postinfect
set
includ
broadli
antivir
activ
strain
african
americanasian
lineag
toxic
cultur
cell
data
support
feasibl
implement
ata
treatment
zikv
infect
african
green
monkey
kidney
epitheli
vero
atcc
human
adenocarcinoma
alveolar
basal
epitheli
atcc
cell
maintain
dulbecco
modifi
eagl
medium
dmem
mediatech
inc
supplement
fetal
bovin
serum
fb
psg
uml
penicillin
streptomycin
mm
lglutamin
atmospher
zikv
isol
kindli
provid
stephen
dewhurst
depart
microbiolog
immunolog
univers
rochest
strain
catalog
ibh
strain
catalog
zikv
isol
obtain
biodefens
emerg
infect
research
resourc
repositori
bei
resourc
puerto
strain
french
zikv
isol
kindli
provid
center
diseas
control
prevent
cdc
viru
stock
propag
vero
cell
titrat
plaqu
assay
previous
describ
marquezjurado
et
al
aurintricarboxyl
acid
catalog
arbidol
arb
catalog
purchas
sigmaaldrich
mo
unit
state
compound
prepar
mm
stock
solut
dissolv
dimethyl
sulfoxid
dmso
kept
experiment
use
drug
dilut
infecti
media
dmem
fb
psg
describ
experi
maximum
dmso
concentr
cell
viabil
vero
cell
measur
use
celltit
nonradioact
cell
prolifer
assay
promega
follow
manufactur
instruct
briefli
confluent
vero
cell
plate
format
cellswel
triplic
treat
dmem
contain
serial
dilut
twofold
dilut
start
concentr
chemic
dmso
vehicl
control
plate
incub
atmospher
h
sampl
treat
dye
solut
incub
atmospher
h
next
cell
treat
solubil
solutionstop
mix
absorb
nm
measur
use
vmax
kinet
micropl
reader
molecular
devic
waltham
unit
state
viabil
compoundtr
cell
calcul
percentag
rel
valu
obtain
dmsotreat
cell
nonlinear
regress
curv
median
cytotox
concentr
calcul
use
graphpad
prism
softwar
version
confluent
monolay
format
cellswel
triplic
vero
cell
infect
plaqu
form
unit
pfu
well
puerto
french
zikv
strain
infect
media
h
adsorpt
viru
inoculum
remov
cell
wash
three
time
infect
media
ad
fresh
infect
media
contain
microcrystallin
cellulos
avicel
sigmaaldrich
indic
concentr
compound
dmso
vehicl
control
case
pretreat
experi
cell
monolay
treat
indic
concentr
compound
dmso
indic
time
zikv
infect
infect
cell
incub
h
depend
viru
strain
immunostain
cell
fix
paraformaldehyd
h
wash
three
time
phosphat
buffer
salin
pb
permeabil
triton
min
room
temperatur
plate
block
bovin
serum
albumin
bsa
pb
block
solut
h
room
temperatur
follow
incub
panflaviviru
envelop
e
protein
monoclon
antibodi
atcc
catalog
dilut
block
solut
h
incub
primari
antibodi
cell
wash
three
time
pb
develop
vectastain
abc
kit
dab
peroxidas
substrat
kit
vector
laboratori
inc
ca
unit
state
accord
manufactur
instruct
stain
plaqu
analyz
use
ctl
immunospot
plate
reader
count
softwar
cellular
technolog
limit
cleveland
oh
unit
state
viru
titer
calcul
pfuml
nogal
et
al
nonlinear
regress
curv
median
inhibitori
concentr
determin
describ
confluent
monolay
plate
format
cellswel
triplic
vero
cell
infect
multipl
infect
moi
dilut
infect
media
h
room
temperatur
viral
absorpt
cell
incub
infect
media
contain
indic
concentr
ata
h
postinfect
h
pi
tissu
cultur
supernat
collect
titrat
vero
cell
immunostain
describ
previous
marquezjurado
et
al
level
apoptosi
measur
use
assay
promega
wi
unit
state
follow
manufactur
instruct
briefli
vero
cell
plate
format
cellswel
triplic
infect
zikv
moi
indic
time
postinfect
cell
tissu
cultur
supernat
collect
centrifug
twenti
five
microlit
supernat
mix
reagent
use
plate
shaker
incub
room
temperatur
h
luminesc
nm
measur
use
spectramax
molecular
devic
waltham
unit
state
follow
manufactur
instruct
twoway
anova
use
evalu
signific
differ
data
express
mean
standard
deviat
sd
least
three
independ
experi
triplic
use
microsoft
excel
softwar
valu
consid
statist
signific
data
analyz
prism
softwar
version
graphpad
softwar
ca
unit
state
determin
use
sigmoid
dose
respons
curv
graphpad
softwar
ca
unit
state
select
index
si
compound
calcul
divid
examin
inhibitori
effect
ata
figur
zikv
infect
first
determin
ata
vero
cell
figur
treat
cell
line
serial
twofold
dilut
ata
measur
cell
viabil
h
posttreat
intern
control
studi
use
arb
drug
previous
describ
antivir
activ
zikv
vero
haviernik
et
al
fink
et
al
cell
observ
toxic
ata
vero
figur
figur
cell
h
posttreat
even
highest
concentr
test
arb
show
valu
vero
figur
figur
cell
tabl
h
posttreat
respect
determin
ata
vero
cell
infect
pfuwel
h
viral
absorpt
viru
inoculum
replac
infect
media
twofold
serial
dilut
start
concentr
ata
arb
figur
calcul
describ
section
materi
method
although
ata
figur
arb
figur
vero
cell
similar
respect
select
index
si
ata
significantli
higher
arb
tabl
likewis
ata
figur
arb
figur
cell
similar
clearli
differ
si
valu
ata
arb
tabl
notabl
si
arb
similar
previous
describ
literatur
cell
line
fink
et
al
haviernik
et
al
data
suggest
ata
exhibit
effect
inhibit
zikv
infect
limit
toxic
si
valu
better
previous
describ
arb
also
observ
zikv
replic
complet
inhibit
concentr
ata
vero
figur
figur
cell
concentr
ata
show
partial
viral
inhibit
vero
cell
figur
b
respect
demonstr
dosedepend
inhibit
viral
replic
cell
line
next
evalu
abil
ata
protect
cell
cytopath
effect
cpe
induc
zikv
infect
figur
end
vero
cell
infect
moi
h
viral
absorpt
cell
treat
ata
h
pi
cell
observ
light
microscop
evalu
morpholog
cpe
figur
expect
previou
result
clearli
ata
abl
prevent
zikvinduc
cpe
cell
line
figur
quantifi
abil
ata
prevent
zikvinduc
apoptosi
tissu
cultur
supernat
zikvinfect
vero
cell
harvest
h
pi
measur
level
apoptot
signal
determin
caspas
activ
figur
zikvinfect
cell
show
increas
caspas
level
eightfold
vero
cell
cell
compar
mockinfect
cell
figur
level
caspas
activ
dosedepend
reduc
ata
ata
show
induct
compar
mockinfect
vero
cell
respect
figur
next
determin
whether
ata
abl
inhibit
ancestor
african
contemporari
asianamerican
puerto
french
zikv
lineag
strain
use
microplaqu
reduct
assay
figur
observ
similar
valu
ata
figur
figur
puerto
figur
french
figur
compar
observ
figur
tabl
demonstr
broad
antivir
activ
ata
differ
zikv
strain
regardless
year
place
isol
demonstr
feasibl
use
ata
prevent
zikv
infect
import
travel
region
zikv
endem
next
evalu
whether
pretreat
ata
result
inhibit
zikv
replic
figur
end
vero
cell
pretreat
ata
figur
figur
figur
figur
h
prior
infect
moi
pretreat
ata
h
zikv
infect
result
similar
valu
respect
demonstr
ata
stabl
abl
prevent
zikv
infect
even
administ
day
previou
viral
infect
figur
tabl
recent
outbreak
zikv
accompani
sever
patholog
includ
microcephali
newborn
prompt
mani
research
develop
prophylact
vaccin
identifi
therapeut
drug
zikv
infect
abbink
et
al
larocca
et
al
lessler
et
al
et
al
fink
et
al
current
commerci
avail
vaccin
andor
antivir
therapi
treatment
zikv
infect
therefor
urgent
medic
need
develop
effect
counter
measur
control
zikv
infect
studi
demonstr
ata
figur
limit
toxic
figur
effect
dosedepend
antivir
activ
zikv
infect
figur
monkey
kidney
epitheli
vero
human
alveolar
cell
notabl
ata
prevent
zikvinduc
cpe
apoptosi
cell
line
figur
broad
antivir
activ
repres
zikv
strain
african
asianamerican
puerto
french
lineag
figur
moreov
ata
also
prevent
zikv
infect
even
administ
day
infect
figur
aurintricarboxyl
acid
polyanion
aromat
compound
structur
relat
suramin
balzarini
et
al
believ
influenc
host
viral
enzym
shadrick
et
al
although
exact
mechan
ata
inhibit
zikv
infect
identifi
studi
sever
plausibl
mechan
zikv
inhibit
mediat
ata
includ
target
viral
cellular
protein
term
inhibit
viral
protein
ata
could
bind
zikv
helicas
prevent
bind
either
atp
nucleic
acid
previous
describ
hcv
mukherje
et
al
shadrick
et
al
likewis
ata
could
inhibit
zikv
rnadepend
rna
polymeras
rdrp
protein
describ
hcv
chen
et
al
mukherje
et
al
shadrick
et
al
enteroviru
hung
et
al
similarli
ata
could
inhibit
methyltransferas
activ
involv
mrna
cap
process
previous
describ
flavivirus
denv
yfv
milani
et
al
garcia
et
al
structur
similar
denv
zikv
protein
feasibl
similar
denv
ata
bind
inhibit
zikv
infect
garcia
et
al
moreov
possibl
ata
target
inhibitori
activ
one
viral
protein
describ
term
target
cellular
protein
import
effici
replic
zikv
previous
describ
ata
antiapoptot
properti
varieti
cell
chen
et
al
possibl
antiapoptot
activ
ata
protect
zikvinduc
cell
death
demonstr
studi
figur
notabl
recent
shown
zikv
infect
induc
apoptosi
caspas
cell
caspas
neonat
mice
brain
huang
et
al
frumenc
et
al
result
suggest
inhibit
zikv
replic
result
decreas
level
apoptot
cell
antiapoptot
effect
ata
affect
zikv
replic
research
guarante
yield
better
understand
antivir
activ
ata
zikv
infect
virus
use
ata
antivir
drug
januari
februari
total
resid
state
unit
state
diagnos
zikv
infect
armstrong
et
al
patient
travel
area
activ
zikv
transmiss
infect
five
travel
report
sexual
contact
travel
symptomat
ill
armstrong
et
al
reason
prevent
effort
requir
prior
travel
area
activ
zikv
transmiss
studi
cell
pretreat
ata
h
prior
infect
zikv
show
similar
posttreat
set
potenti
suggest
ata
might
target
cellular
protein
requir
zikv
replic
concentr
stabil
ata
pretreat
cell
suffici
inhibit
zikv
infect
nevertheless
result
demonstr
feasibl
use
ata
prophylact
treatment
viral
infect
includ
travel
area
zikv
endem
moreov
due
broad
inhibit
effect
ata
other
virus
parasit
liang
et
al
et
al
de
clercq
myskiw
et
al
klein
et
al
chen
et
al
hung
et
al
mukherje
et
al
shadrick
et
al
present
zikv
endem
area
treatment
ata
could
use
broad
prevent
denv
yfv
milani
et
al
shadrick
et
al
garcia
et
al
hcv
chen
et
al
mukherje
et
al
shadrick
et
al
parasit
infest
cryptosporidium
parvum
klein
et
al
peopl
travel
endem
region
moreov
broad
spectrum
antivir
activ
ata
differ
african
asianamerican
zikv
strain
guarante
feasibl
implement
ata
prevent
zikv
infect
travel
around
world
although
ata
ampli
evalu
vitro
studi
assess
activ
ata
vivo
includ
use
cur
agent
thrombosi
stroni
et
al
apoptosi
robertslewi
et
al
heiduschka
thano
parasit
infest
klein
et
al
bacteri
pesti
liang
et
al
vaccinia
viru
smee
et
al
infect
case
vaccinia
viru
ata
protect
mice
lethal
challeng
dose
mgkgday
smee
et
al
studi
need
evalu
antivir
activ
ata
vivo
treatment
viral
infect
includ
zikv
studi
show
limit
toxic
ata
cultur
cell
includ
human
cell
lack
knowledg
use
ata
pregnant
women
requir
futur
addit
safeti
test
includ
studi
use
valid
anim
model
zikv
infect
use
ata
treatment
zikv
infect
pregnanc
base
effect
ata
zikv
infect
si
vero
cell
cell
compar
previous
describ
drug
includ
emetin
si
cell
env
cell
yang
et
al
obatoclax
si
human
retin
pigment
epitheli
rpe
cell
kuivanen
et
al
saliphenylhalamid
si
rpe
cell
kuivanen
et
al
gemcitabin
si
rpe
cell
kuivanen
et
al
sofosbuvir
si
cell
jar
cell
bullardfeibelman
et
al
arb
si
vero
cell
cell
fink
et
al
haviernik
et
al
studi
ata
si
vero
cell
cell
possibl
ata
repres
one
reason
option
treatment
zikv
infect
jgp
fm
conceiv
design
perform
experi
th
fa
lm
provid
reagent
suggest
resourc
fa
lm
provid
fund
jgp
analyz
data
wrote
initi
manuscript
draft
fm
th
fa
lm
edit
origin
draft
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
